I Tested The Best Korean Skincare Brands Against My Fragile, Sensitive Skin. These Are the Ones That Worked

Why we like it: If you're familiar with K-beauty, chances are you have heard of Beauty of Joseon. This brand went especially viral on social media. It is known for having a diverse product lineup for all skin concerns. I tested the popular Apricot Blossom Peeling Gel and the Ginseng Essence Water on my dry and sensitive skin. I highly recommend the peeling gel. Its grittiness is made of plant-based cellulose that gently exfoliates the skin and addresses texture issues. It has a slight scent, but the ingredients have never been too harsh or irritating to my skin. I love how soft my face feels after using the gel.
Who is it best for: This brand is great for those with sensitive skin, like me. I haven't had any reaction to the products that I have tested, and according to my extensive research online in K-beauty forums, this resonates with many others with sensitive skin. Since the brand has so many products to offer, this might be a good brand to try for newcomers.
Who should not get it: Those with acne-prone or extremely oily skin may be a bit wary of some of the oil-based products, especially products that contain coconut oil. It may clog pores or irritate the skin.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Buzz Feed

an hour ago

• Buzz Feed

31 Best Korean Skincare Products

An Anua pore-clearing cleansing oil that visibly sucks out sebum from your pores and removes makeup residue and blackheads, leaving your skin looking clearer and feeling smoother. Reviewers of all skin types swear by it, including those with acne-prone skin (who say it doesn't cause breakouts)! A Beauty of Joseon glow serum, aka the secret ingredient to more glass-like skin. This lightweight serum uses rice bran water and 2% alpha-arbutin, a skin-brightening hero that can help fade hyperpigmentation and acne scars. One reviewer said they don't have to wear as much highlighter because their skin was glowing so much, while another swears they don't even need foundation anymore because their skin tone is so even. The Saem hydrating eye stick, a perfect remedy for dehydrated skin. This eye treatment is made with Icelandic glacier water, giving your skin the fresh hydration boost it needs on days when you've hit the snooze button one too many times. Mixsoon Bean Essence that hydrates and exfoliates your skin at the same dang time. 🤯 This thick (but not sticky) essence contains natural ingredients like fermented bean, barley, and pomegranate to remove dead skin cells and revitalize skin tone. If your skin is more on the sensitive side, a jar of Anua heartleaf daily toner pads made with PHA to gently exfoliate and remove dead skin cells while also helping to reduce blackheads, whiteheads, and breakouts. The heartleaf extract helps to soothe and hydrate skin, leaving you with a glowy complexion. A cute little Tonymoly octopus-shaped blackhead remover that rids your nose and chin of all the gunk that's built up throughout the day and exfoliates pores, making your skin look smoother and cleaner. A Mizon snail repair cream made to reduce the appearance of fine lines and dark spots. It contains raspberry extract, AHA, and mugwort extract to help your skin feel smoother and more rejuvenated than ever. An Elizavecca carbonated clay mask here to remove all the built-up sebum from your face without stripping away your skin's natural oils. Reviewers say after using this their skin feels super clean and irresistibly soft — you won't be able to resist touching it! A lightweight Nooni tinted appleberry lip oil made to hydrate and revitalize even the driest, flakiest lips, breathing life back into your smile. The non-sticky formula leaves you with a juicy glow and sheer, gorgeous color. Also! If you want just the hydrating benefits without any color, it's available in a clear tint too. A lightweight Cosrx mild gel cleanser that's gentle enough for you to lather up and have that fresh face feeling every day. This pH-balanced face wash won't disrupt your skin, which could lead to all sorts of problems like dryness, oiliness, and breakouts. It also contains BHA (a type of exfoliant that unclogs pores) and tea tree oil (which has antibacterial properties that zip zits). A bottle of Glow Recipe Watermelon Glow Niacinamide Dew Drops packed with vitamins that help plump and brighten your skin along with hydrating hyaluronic acid and soothing moringa seed oil for an instant dewy glow. ✨ An intensive Tocobo glazed lip balm that practically melts into every nook and cranny of your chapped lips, creating a glazed coating that locks in hydration and adds a luscious glow. It contains a PHA that (without getting too science-y) gently buffs away any rough patches while keeping your lip's pH in check, leaving a kissable finish. A Medicube Age-R Booster Pro if you want to feel like you just left a Korean skin clinic without having to hop on a flight. This device features four different treatments, all powered by LED light therapy, that can exfoliate, tighten, boost the efficacy of your other products, and rejuvenate your skin. It announces the minutes as you're using it to ensure you don't overuse it in one spot and doesn't take long to see noticeable results. A brightening Elizabeth Mott vitamin C face scrub that'll leave your skin feeling irresistibly soft and radiant. This scrub has just the right amount of graininess to thoroughly exfoliate without causing irritation. Plus, the ~heat-activated~ exfoliation creates a delightful warming sensation as you massage it onto your skin, which reviewers absolutely adore. A fast-working calming cream by Dear, Klairs with a natural extract from chamomile oil that hydrates the skin and helps relieve redness. It can be good to use after laser treatment, long-term sun exposure, or post-shaving. A five-second Dr. Groot scalp treatment to encourage stronger, fuller hair growth in case you're dealing with thinning, breakage, or even a perm mishap. This revitalizing formula cleanses, exfoliates, and deeply hydrates your scalp all in one go, and reviewers can't get enough of it — many rave that their hair felt smoother and softer after the first use, and one person even noticed a difference in thickness within a week. A bottle of Beauty of Joseon rice toner in case you need a little extra help with hydration, especially if you live in a dry environment. This toner gives the skin a lovely illuminating effect while also improving its protective moisture barrier. A SeoulCeuticals toner mist made with 98% naturally derived ingredients like refreshing cucumber, antioxidant-rich green tea, tamarind, soothing aloe, and rejuvenating marine minerals for a perfect dose of dewy radiance. This powerhouse mist not only hydrates and plumps your skin but also works its magic on blemishes, helping keep those pesky breakouts at bay. A "lifting" Numbuzin essence that reviewers on TikTok are referring to as "Botox in a bottle." It's made with NAD+, which can help boost cell turnover and stimulate collagen production, along with 50 types of peptides to help plump and firm your skin. With a stretchy texture that's similar to snail mucin but thicker, this gem can help make fine lines and wrinkles less noticeable in four weeks! A Seraphic exfoliating scrub mitt made with viscose fiber that's rough enough to visibly lift dead skin away but also buffs and smoothes, leaving your skin velvety soft. Reviewers also use this mitt to help with ingrown hairs and to remove spray tan. An antioxidant-rich D'Alba spray serum infused with white truffle extract to deeply nourish flaky skin and keep your glow on point! It's great for prepping your skin for makeup *and* sealing your look with a dewy finish that'll rival your favorite Insta filter — and when you're out and about, you can reach for it anytime you need a refreshing boost of hydration. Rael Beauty's Miracle Patch, which is designed to draw out the gunk from your pimples while creating a protective shield (if you find yourself tempted to pick at them). Unlike other patches, this one has edges so thin that they practically blend in with your skin — perfect for those times when you need a little acne-fighting magic but still want to go about your day without anyone noticing A Dr. Althea cleansing balm made with this innovative grinding mechanism so you get *just* the right amount of product you need, and it's also way more hygienic than sticking your fingers into a container. It's formulated with plant-based oils that can remove sunscreen, makeup, and even waterproof mascara! An Innisfree daily UV defense sunscreen reviewers are calling their "holy grail" sun protection. It has SPF 36, which is *chef's kiss* for everyday use. It's formulated with green tea for hydration, cica to soothe redness and irritation, and sunflower seed oil to nourish the skin. And the best part? It leaves behind a beautiful glow with zero white cast. A pair of Plantifique moisturizing booties to intensely hydrate and repair your dry, rough, cracked feet. If you don't want to deal with those foot peel masks that can take up to a week for the final result, give these a try — they'll make your piggies baby soft in only 30 minutes! A nourishing CNP lip butter made with manuka honey. It's so deeply hydrating, it's basically a lip mask in disguise — your lips will stay hydrated and luscious for 12 hours straight! It has a special air-fit, dial-turning container so you can dispense the exact amount of product that you need, keeping things hygienic while also protecting the efficacy of the active ingredients. Belif Aqua Bomb, a gel-based moisturizer reviewers *rave* about for its lightweight, watery texture and refreshing cooling effect. In just 10 seconds, it absorbs without any stickiness while delivering a surge of moisture, leaving your face feeling plump and looking radiant. Soothing VT Cosmetics cica sheet masks — this hydrating, non-sticky formula is designed for daily use, featuring three types of hyaluronic acid, propolis extract, and (the star of the show) centella extract. The mask clings to your face tightly, so you can easily wear it while getting ready in the morning, and the moisture absorbs quickly, delivering a fresh burst of hydration for the day ahead. A Purito bamboo panthenol cream formulated to deeply hydrate, repair, and strengthen your skin barrier. It also works wonders for balancing your oil production and reducing inflammation, leaving your skin so smooth and radiant, you'll look like you just stepped out of a skincare ad. A popular pack of Skin1004 8-in-1 treatment masks ready to give you similar (if not better) results as the v expensive Hanacure, if you don't mind looking like a zombie for 15 minutes in exchange for (*takes a deep breath*): reduced fine lines, lifted skin, cleared acne, tightened pores, deeply hydrated skin, improved skin texture, balanced pH level, and a brightened complexion. The all-in-one Kahi Wrinkle Bounce Hydrating Multi-Balm for those dry areas on your face and body that could use a little extra love. Packed with collagen and a natural fermented oil straight from Jeju Island, this balm is like a loving hug for your skin, giving it a 48-hour moisture boost and lifting effect.

Yahoo

4 hours ago

• Yahoo

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically significant reductions in mean monthly migraine days (MMDs) compared with placebo1 Patients receiving eptinezumab were four times more likely to achieve a reduction of ≥75% in MMDs within the first 4 weeks, compared to placebo1 The SUNRISE trial met all key secondary efficacy endpoints with improvements seen as early as day 1 and sustained through week 121 VALBY, Denmark, June 21, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced the full results from the SUNRISE trial, a randomized, placebo-controlled trial designed to evaluate the efficacy and safety of eptinezumab versus placebo in a predominantly Asian population with chronic migraine. The study was presented at the 11th Congress of the European Academy of Neurology taking place in Helsinki 21-24 June.1 "Various treatments are recommended for patients with migraine in Asia, however utilization and adherence to migraine-specific treatment is relatively low. Access to effective treatments remains a significant unmet medical need for migraine prevention in Asia" said Johan Luthman, EVP and Head of R&D at Lundbeck. "The data from SUNRISE is consistent with previous results across diverse populations and will be pivotal for our efforts to expand access to eptinezumab for patients in Asia suffering with severe migraine." The double-blind, pivotal, SUNRISE trial (n=983) met all key primary and secondary endpoints, with eptinezumab demonstrating greater reductions in migraine frequency, the proportion of migraine attacks with severe pain, and disease burden, compared to placebo.1 "The SUNRISE trial marks a significant step forward in the mission to make migraine-specific preventive treatments more globally accessible, ensuring that patients with severe migraine receive the care they need" said Dr Patricia Pozo-Rosich, Head of Section of the Neurology Department, Director of Headache and Craniofacial Pain Clinical Unit and the Migraine Adaptive Brain Center at the Vall d'Hebron University Hospital in Barcelona, and principal investigator in the SUNRISE trial. In the SUNRISE trial, patients receiving eptinezumab experienced significantly fewer monthly migraine days (MMDs), with eptinezumab offering a -7.5 (300 mg) and -7.2 (100 mg) reduction in MMDs from week 1 through to 12, versus -4.8 with placebo (baseline MMD = 17, p<0.0001 for both 300 mg and 100 mg vs placebo).1 Amongst other parameters, patients receiving eptinezumab (300 mg or 100 mg) were four times more likely to achieve a reduction of ≥75% in the number of migraine days per month, compared to placebo within the first 4 weeks (p<0.0001).1 In the same study, eptinezumab also demonstrated a rapid onset of preventive efficacy, where more participants reported being free of migraine as early as day 1 after receiving eptinezumab treatment compared to placebo (p<0.002 for 300 mg dose; p<0.01 for 100 mg dose). This clinical efficacy was also reflected in patient reported outcomes where patients reported clinically meaningful improvements which were greater with eptinezumab than with placebo.1 Finally, the safety profile of eptinezumab was generally similar to placebo, previous trials, and to the current labelled safety information in the United States prescribing information and EU Summary of Product Characteristics, with the most common treatment-emergent adverse events being COVID-19 and nasopharyngitis.1 Based on the SUNRISE results, Lundbeck has initiated discussions with relevant regulatory authorities with the aim of making eptinezumab available for people suffering from migraine across Asia. About migraine Migraine is a complex and incapacitating neurological disease characterized by recurrent episodes of severe headaches typically accompanied by an array of symptoms, including nausea, vomiting, and sensitivity to light or sound. Not only is headache painful, but migraine also imposes both a social and financial burden. Migraine has a profound impact on patient functioning including relationships with family/friends, leisure activities, household production and worker productivity. Migraine is one of the most prevalent neurological diseases for which medical treatment is sought, and worldwide, is considered the leading cause of disability for people under the age of 50 and the 2nd leading cause of disability worldwide.3,4 Repeated headache attacks, and often the constant fear of the next one, damage family life, social life and work life. Furthermore, frequent use of acute migraine treatments may leave patients experiencing, or at risk of developing, medication overuse headache. Despite equally high prevalence of migraine in Asia as compared western countries, significant unmet needs remain in terms of sufficient and appropriate diagnosis, and better management and therapies for treatment of migraine in East Asia.5 In China, an estimated 14.3% of adults are living with migraine. From this population, approximately 52.9% will visit hospitals and only 13.8% of them will be diagnosed with migraine.6 About the SUNRISE trial SUNRISE (NCT04921384) is an interventional, multi-regional, multi-site, randomized, double-blind, placebo-controlled phase III trial, to confirm the efficacy and safety of eptinezumab in participants with chronic migraine who are eligible for preventive treatment.2 The study was conducted to support marketing authorization across Asia. Chronic migraine was defined as migraine occurring on ≥8 days per month and headache occurring on >14 days. Participants were randomly allocated to one of three treatment groups: eptinezumab 300 mg, eptinezumab 100 mg, or placebo. The double-blind, placebo-controlled treatment period was followed by an extension period where all participants received active treatment to further assess the safety and tolerability of eptinezumab. The total trial duration from the Screening Visit to the Safety Follow-up Visit is approximately 36 weeks and includes a Screening Period (28-30 days), a Placebo-controlled Period (12 weeks), an Extension Period (12 weeks), and a Safety Follow-up Period (8 weeks).1 Participants in Japan completing the SUNRISE trial were offered to continue in the SUNSET trial (NCT05064371) which consisted of an open-label eptinezumab treatment of 60 weeks (five infusions), and a Safety Follow-up Period (8 weeks). The SUNRISE was initiated in May 2021 and was conducted in Mainland China, Georgia, Japan, Poland, Slovakia, South Korea, Spain and Taiwan. In the trial, 983 participants were randomized to receive eptinezumab 100 mg or 300 mg or placebo by intravenous (IV) infusion.2 About Vyepti® (eptinezumab) Eptinezumab is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) which was intentionally designed for IV administration. The efficacy and safety of eptinezumab was evaluated in two phase III clinical trials (PROMISE-1 in episodic migraine7 and PROMISE-2 in chronic migraine8), where eptinezumab met its primary endpoint of decrease in MMDs over weeks 1-12 in both episodic and chronic migraine. Furthermore, the clinical trial program demonstrated a treatment benefit over placebo that was observed for both doses of eptinezumab as early as day 1 post-infusion. The safety of eptinezumab was evaluated in more than 2,000 adult patients with migraine who received at least one dose of eptinezumab. The most common adverse reactions (≥2% and at least 2% or greater than placebo) in the clinical trials for the preventive treatment of migraine were nasopharyngitis and hypersensitivity. In PROMISE-1 and PROMISE-2, 1.9% of patients treated with eptinezumab discontinued treatment due to adverse reactions. Vyepti® (eptinezumab-jjmr) was approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in adults in February 2020, and in January 2022, eptinezumab was granted marketing authorization by the European Commission (EC) for the prophylaxis of migraine in adults who have at least four migraine days per month. Today, eptinezumab is launched in more than 30 markets worldwide. Contacts Marie Petterson Jens Høyer Head of Media Relations, Corp. Communication Vice President, Head of Investor Relations MEEP@ JSHR@ +45 29 82 21 82 +45 30 83 45 01Palle Holm OlesenVice President, Investor RelationsPALO@ 30 83 24 26 About H. Lundbeck A/S Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world's population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has approximately 5,700 employees in more than 50 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site and connect with us via LinkedIn. References: Yu S, ePresentation at EAN Congress 2025 H. Lundbeck A/S. Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine (Sunrise). NCT04921384 Steiner TJ, Stovner LJ, Vos T. et al. J Headache Pain 2018; 19: 17. Leonardi M, Steiner TJ, Scher AT, Lipton RB. J Headache Pain. 2005; 6(6): 429– 440. Takeshima, T, et al. J Headache Pain 2019; 20, 111 Guidelines for the diagnosis and treatment of migraine in China (2022 edition). Chinese Journal of Pain Medicine 2022, 28 (12) Ashina M, et al. Cephalalgia. 2020 Mar;40(3):241-254. Lipton RB, et al. Neurology. 2020 Mar 31;94(13):e1365-e1377. CONTACT: H. Lundbeck A/SOttiliavej 9, 2500 Valby, Denmark+45 3630 1311info@ This information was brought to you by Cision The following files are available for download: EAN 2025 Press Release SUNRISE_Final View original content:

Yahoo

12 hours ago

• Yahoo

Alcohol linked to increased risk of pancreatic cancer: Study

Alcoholic beverages, particularly beer and spirits, may increase the risk of developing pancreatic cancer, according to a new study led by the UN World Health Organization. The research, which pooled data from nearly 2.5 million people across Asia, Australia, Europe and North America, revealed a 'modest but significant' link between alcohol consumption and pancreatic cancer risk, regardless of sex or smoking status. 'Alcohol consumption is a known carcinogen, but until now, the evidence linking it specifically to pancreatic cancer has been considered inconclusive,' said Pietro Ferrari, senior author of the study and head of the nutrition and metabolism branch at the World Health Organization International Agency for Research on Cancer. The study revealed that each additional 10 grams of alcohol consumed per day was associated with a three percent increase in pancreatic cancer risk. Additionally, women consuming 15-30 grams of alcohol daily, which equates to about one to two drinks, had a 12 percent higher risk. Men drinking 30-60 grams daily had a 15 percent increased risk, increasing to 36 percent for those consuming more than 60 grams. The study confirmed alcohol as an 'independent risk factor,' even after accounting for smoking. Ferrari emphasized that 'alcohol is often consumed in combination with tobacco,' but the elevated risk persists among non-smokers. Pancreatic cancer, a disease that impacts digestive enzyme production and blood sugar regulation, remains one of the deadliest cancers due to late-stage diagnoses. Although it ranks 12th in global cancer incidence, it accounts for 5 percent of all cancer-related deaths, according to the WHO. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.